5 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp07239 | RB4 | MADSERLSAPGCWAACTNFSRTRK | Derived from protein PLP2 | F-actin modulation induces necrotic death. | MTT assay | B16-F10-Nex 2 | Skin Cancer | EC50 = 0.263 ± 0.585 mol/L × 10-3 |
| dbacp07240 | RB4 | MADSERLSAPGCWAACTNFSRTRK | Derived from protein PLP2 | F-actin modulation induces necrotic death. | MTT assay | HeLa | Cervical Cancer | EC50 = 0.525 ± 0.160 mol/L × 10-3 |
| dbacp07241 | RB4 | MADSERLSAPGCWAACTNFSRTRK | Derived from protein PLP2 | F-actin modulation induces necrotic death. | MTT assay | U-87 | Brain Tumor | EC50 = 0.427 ± 0.053 mol/L × 10-3 |
| dbacp07242 | RB4 | MADSERLSAPGCWAACTNFSRTRK | Derived from protein PLP2 | F-actin modulation induces necrotic death. | MTT assay | A-2058 | Skin Cancer | EC50 = 0.744 ± 0.208 mol/L × 10-3 |
| dbacp07243 | RB4 | MADSERLSAPGCWAACTNFSRTRK | Derived from protein PLP2 | F-actin modulation induces necrotic death. | MTT assay | MCF-7 | Breast Cancer | EC50 = 0.724 ± 0.340 mol/L × 10-3 |